Cargando…

OSWG Recommended Approaches to the Nonclinical Pharmacokinetic (ADME) Characterization of Therapeutic Oligonucleotides

This white paper summarizes the recommendations of the absorption, distribution, metabolism, and excretion (ADME) Subcommittee of the Oligonucleotide Safety Working Group for the characterization of absorption, distribution, metabolism, and excretion of oligonucleotide (ON) therapeutics in nonclinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berman, Cindy L., Antonsson, Madeleine, Batkai, Sandor, Bosgra, Sieto, Chopda, Girish R., Driessen, Wouter, Foy, Jeffrey, Hassan, Chopie, Hu, Xiao Shelley, Jang, Hyun Gyung, Meena, , Sanseverino, Mark, Thum, Thomas, Wang, Yanfeng, Wild, Martin, Wu, Jing-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2023
Materias:	Issues in Development
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561745/ https://www.ncbi.nlm.nih.gov/pubmed/37590469 http://dx.doi.org/10.1089/nat.2023.0011

Ejemplares similares

Nonclinical Exon Skipping Studies with 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn−/− Mice Inspired by Clinical Trial Results
por: van Putten, Maaike, et al.
Publicado: (2019)

Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals
por: Hirabayashi, Yoko, et al.
Publicado: (2021)

Pharmacokinetic Studies of Antisense Oligonucleotides Using MALDI-TOF Mass Spectrometry
por: Herkt, Markus, et al.
Publicado: (2020)

Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017)

Perspectives on the Designation of Oligonucleotide Starting Materials
por: Kiesman, William F., et al.
Publicado: (2021)

Technical Considerations for Use of Oligonucleotide Solution API
por: Muslehiddinoglu, Jale, et al.
Publicado: (2020)

Considerations for the Terminal Sterilization of Oligonucleotide Drug Products
por: DeCollibus, Daniel Paul, et al.
Publicado: (2023)

Guidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs
por: Gagnon, Keith T., et al.
Publicado: (2019)

Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide
por: Kourkouta, Eleni, et al.
Publicado: (2019)

Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives
por: Synofzik, Matthis, et al.
Publicado: (2022)

Studying Interactions between 2’-O-Me-Modified Inhibitors and MicroRNAs Utilizing Microscale Thermophoresis
por: Herkt, Markus, et al.
Publicado: (2019)

Metabolite Profiling of the Antisense Oligonucleotide Eluforsen Using Liquid Chromatography-Mass Spectrometry
por: Kim, Jaeah, et al.
Publicado: (2019)

Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy
por: van Deutekom, Judith, et al.
Publicado: (2023)

ADME-Space: a new tool for medicinal chemists to explore ADME properties
por: Bocci, Giovanni, et al.
Publicado: (2017)

Epitope Mapping: The First Step in Developing Epitope-Based Vaccines
por: Gershoni, Jonathan M., et al.
Publicado: (2012)

Nonclinical statistics for pharmaceutical and biotechnology industries
por: Zhang, Lanju
Publicado: (2016)

Strategies for the Nonclinical Safety Assessment of Vaccines
por: Wolf, Jayanthi J., et al.
Publicado: (2012)

Altered expression of ADM and ADM2 by hypoxia regulates migration of trophoblast and HLA-G expression
por: Gu, Changdai, et al.
Publicado: (2020)

Recruiting patients and collecting data for an observational study using computerised record pop-up prompts: the PROG-RES study
por: Hayward, Richard A., et al.
Publicado: (2012)

The Continuum of Comparability Extends to Biosimilarity: How Much Is Enough and What Clinical Data Are Necessary?
por: McCamish, M, et al.
Publicado: (2013)

Improving capacity in ethnicity and health research: report of a tailored programme for NHS Public Health practitioners
por: Salway, Sarah, et al.
Publicado: (2012)

The Signature Program: Bringing the Protocol to the Patient
por: Kang, BP, et al.
Publicado: (2015)

Families First: the development of a new mentalization-based group intervention for first-time parents to promote child development and family health
por: Kalland, Mirjam, et al.
Publicado: (2015)

Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease
por: Cummings, J, et al.
Publicado: (2015)

Digital technologies for cognitive assessment to accelerate drug development in Alzheimer's disease
por: Leurent, C, et al.
Publicado: (2015)

Potential Psychiatric Uses for MDMA
por: Yazar‐Klosinski, BB, et al.
Publicado: (2017)

Harnessing the Power of Real‐World Evidence (RWE): A Checklist to Ensure Regulatory‐Grade Data Quality
por: Miksad, Rebecca A., et al.
Publicado: (2017)

Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development
por: Gibbs, John P., et al.
Publicado: (2017)

Development of Molecularly Targeted Therapies to Treat Pediatric Malignancies
por: Stewart, Clinton F., et al.
Publicado: (2017)

Does characterising patterns of multimorbidity in stroke matter for developing collaborative care approaches in primary care?
por: Aquino, Maria Raisa Jessica (Ryc) V, et al.
Publicado: (2019)

Substance misuse in later life: challenges for primary care: a review of policy and evidence
por: Rao, Rahul, et al.
Publicado: (2019)

Access to care of frail community-dwelling older adults in Belgium: a qualitative study
por: Fret, Bram, et al.
Publicado: (2019)

Analysis of evidence appraisals for interventional studies in family medicine using an informatics approach
por: Sahin, Alain Nathan, et al.
Publicado: (2019)

Toward interchangeable biologics
por: McCamish, M, et al.
Publicado: (2015)

Policy proposals for a new welfare: the development of the family and community nurse in Italy as the key to promote social capital and social innovation
por: Marcadelli, Silvia, et al.
Publicado: (2019)

Integrated people-centred primary health care in Greece: unravelling Ariadne’s thread
por: Lionis, Christos, et al.
Publicado: (2019)

Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma
por: Xu, XS, et al.
Publicado: (2017)

Cancer Moonshot Data and Technology Team: Enabling a National Learning Healthcare System for Cancer to Unleash the Power of Data
por: Hsu, ER, et al.
Publicado: (2017)

A five-step approach for developing and implementing a Rural Primary Health Care Model for Dementia: a community–academic partnership
por: Morgan, Debra, et al.
Publicado: (2019)

Decentralised clinical training in optometry: a developmental strategy for eye health in KwaZulu Natal?
por: van Staden, Diane
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ais2aaj590jm0v4rkf41gh6ifn